Loading…

Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure

Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmit...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular research 2014-10, Vol.104 (1), p.183-193
Main Authors: Yamada, Yuko, Kinoshita, Hideyuki, Kuwahara, Koichiro, Nakagawa, Yasuaki, Kuwabara, Yoshihiro, Minami, Takeya, Yamada, Chinatsu, Shibata, Junko, Nakao, Kazuhiro, Cho, Kosai, Arai, Yuji, Yasuno, Shinji, Nishikimi, Toshio, Ueshima, Kenji, Kamakura, Shiro, Nishida, Motohiro, Kiyonaka, Shigeki, Mori, Yasuo, Kimura, Takeshi, Kangawa, Kenji, Nakao, Kazuwa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73
cites cdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73
container_end_page 193
container_issue 1
container_start_page 183
container_title Cardiovascular research
container_volume 104
creator Yamada, Yuko
Kinoshita, Hideyuki
Kuwahara, Koichiro
Nakagawa, Yasuaki
Kuwabara, Yoshihiro
Minami, Takeya
Yamada, Chinatsu
Shibata, Junko
Nakao, Kazuhiro
Cho, Kosai
Arai, Yuji
Yasuno, Shinji
Nishikimi, Toshio
Ueshima, Kenji
Kamakura, Shiro
Nishida, Motohiro
Kiyonaka, Shigeki
Mori, Yasuo
Kimura, Takeshi
Kangawa, Kenji
Nakao, Kazuwa
description Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure. We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice. Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.
doi_str_mv 10.1093/cvr/cvu185
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566112286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1566112286</sourcerecordid><originalsourceid>FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</originalsourceid><addsrcrecordid>eNo9UcuO1DAQtBCInV248AGojwgU8GNsJ0c04rHSCi5wjtpORzFKnMF2Bs2v8LV4NcseWtUlVZXUXYy9Evy94J364E-pziZa_YTthNW6UXKvn7Id57xtjDLqil3n_KtSre3-ObuSWnBujd2xv7dxCi6UsEZYR_jWlPOR4IDyHfgJY6Q5Ay40hzVhobpHCIvDGaMnCBE8piGgB9zKGtcleIiUTgToSziFcq6GAY6JThRLhpnKhDNgStO5TEvAfJ9RXQR_QplgIkwFRgzzlugFezbinOnlA96wn58__Th8be6-f7k9fLxrvNSqNK3tNLdkhVJ6tEhcOiX1iHvpXKXCSHLYOaPQaMf3neK2QtuNcjCDJqtu2JtL7jGtvzfKpV9C9jTXG2ndci-0MUJI2ZoqfXuR-rTmnGjsjyksmM694P19F33tor90UcWvH3I3t9DwKP3_fPUPG06IRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566112286</pqid></control><display><type>article</type><title>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</title><source>Oxford Journals Online</source><creator>Yamada, Yuko ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Nakagawa, Yasuaki ; Kuwabara, Yoshihiro ; Minami, Takeya ; Yamada, Chinatsu ; Shibata, Junko ; Nakao, Kazuhiro ; Cho, Kosai ; Arai, Yuji ; Yasuno, Shinji ; Nishikimi, Toshio ; Ueshima, Kenji ; Kamakura, Shiro ; Nishida, Motohiro ; Kiyonaka, Shigeki ; Mori, Yasuo ; Kimura, Takeshi ; Kangawa, Kenji ; Nakao, Kazuwa</creator><creatorcontrib>Yamada, Yuko ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Nakagawa, Yasuaki ; Kuwabara, Yoshihiro ; Minami, Takeya ; Yamada, Chinatsu ; Shibata, Junko ; Nakao, Kazuhiro ; Cho, Kosai ; Arai, Yuji ; Yasuno, Shinji ; Nishikimi, Toshio ; Ueshima, Kenji ; Kamakura, Shiro ; Nishida, Motohiro ; Kiyonaka, Shigeki ; Mori, Yasuo ; Kimura, Takeshi ; Kangawa, Kenji ; Nakao, Kazuwa</creatorcontrib><description>Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure. We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice. Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvu185</identifier><identifier>PMID: 25100767</identifier><language>eng</language><publisher>England</publisher><subject>Adrenergic beta-Antagonists - pharmacology ; Animals ; Anti-Arrhythmia Agents - pharmacology ; Arrhythmias, Cardiac - genetics ; Arrhythmias, Cardiac - metabolism ; Arrhythmias, Cardiac - physiopathology ; Arrhythmias, Cardiac - prevention &amp; control ; Autonomic Nervous System - drug effects ; Autonomic Nervous System - metabolism ; Autonomic Nervous System - physiopathology ; Calcium Channel Blockers - pharmacology ; Calcium Channels, L-Type - drug effects ; Calcium Channels, L-Type - metabolism ; Calcium Channels, N-Type - drug effects ; Calcium Channels, N-Type - genetics ; Calcium Channels, N-Type - metabolism ; Cardiomyopathy, Dilated - drug therapy ; Cardiomyopathy, Dilated - genetics ; Cardiomyopathy, Dilated - metabolism ; Cardiomyopathy, Dilated - physiopathology ; Death, Sudden, Cardiac - etiology ; Death, Sudden, Cardiac - prevention &amp; control ; Dihydropyridines - pharmacology ; Disease Models, Animal ; Heart - innervation ; Heart Failure - drug therapy ; Heart Failure - genetics ; Heart Failure - metabolism ; Heart Failure - physiopathology ; Mice, Knockout ; Mice, Transgenic ; Nitrendipine - pharmacology ; Repressor Proteins - genetics ; Repressor Proteins - metabolism ; Time Factors ; Ventricular Function, Left - drug effects</subject><ispartof>Cardiovascular research, 2014-10, Vol.104 (1), p.183-193</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</citedby><cites>FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25100767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Yuko</creatorcontrib><creatorcontrib>Kinoshita, Hideyuki</creatorcontrib><creatorcontrib>Kuwahara, Koichiro</creatorcontrib><creatorcontrib>Nakagawa, Yasuaki</creatorcontrib><creatorcontrib>Kuwabara, Yoshihiro</creatorcontrib><creatorcontrib>Minami, Takeya</creatorcontrib><creatorcontrib>Yamada, Chinatsu</creatorcontrib><creatorcontrib>Shibata, Junko</creatorcontrib><creatorcontrib>Nakao, Kazuhiro</creatorcontrib><creatorcontrib>Cho, Kosai</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Yasuno, Shinji</creatorcontrib><creatorcontrib>Nishikimi, Toshio</creatorcontrib><creatorcontrib>Ueshima, Kenji</creatorcontrib><creatorcontrib>Kamakura, Shiro</creatorcontrib><creatorcontrib>Nishida, Motohiro</creatorcontrib><creatorcontrib>Kiyonaka, Shigeki</creatorcontrib><creatorcontrib>Mori, Yasuo</creatorcontrib><creatorcontrib>Kimura, Takeshi</creatorcontrib><creatorcontrib>Kangawa, Kenji</creatorcontrib><creatorcontrib>Nakao, Kazuwa</creatorcontrib><title>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure. We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice. Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.</description><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>Arrhythmias, Cardiac - genetics</subject><subject>Arrhythmias, Cardiac - metabolism</subject><subject>Arrhythmias, Cardiac - physiopathology</subject><subject>Arrhythmias, Cardiac - prevention &amp; control</subject><subject>Autonomic Nervous System - drug effects</subject><subject>Autonomic Nervous System - metabolism</subject><subject>Autonomic Nervous System - physiopathology</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Calcium Channels, L-Type - drug effects</subject><subject>Calcium Channels, L-Type - metabolism</subject><subject>Calcium Channels, N-Type - drug effects</subject><subject>Calcium Channels, N-Type - genetics</subject><subject>Calcium Channels, N-Type - metabolism</subject><subject>Cardiomyopathy, Dilated - drug therapy</subject><subject>Cardiomyopathy, Dilated - genetics</subject><subject>Cardiomyopathy, Dilated - metabolism</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Death, Sudden, Cardiac - etiology</subject><subject>Death, Sudden, Cardiac - prevention &amp; control</subject><subject>Dihydropyridines - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Heart - innervation</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - genetics</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - physiopathology</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Nitrendipine - pharmacology</subject><subject>Repressor Proteins - genetics</subject><subject>Repressor Proteins - metabolism</subject><subject>Time Factors</subject><subject>Ventricular Function, Left - drug effects</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9UcuO1DAQtBCInV248AGojwgU8GNsJ0c04rHSCi5wjtpORzFKnMF2Bs2v8LV4NcseWtUlVZXUXYy9Evy94J364E-pziZa_YTthNW6UXKvn7Id57xtjDLqil3n_KtSre3-ObuSWnBujd2xv7dxCi6UsEZYR_jWlPOR4IDyHfgJY6Q5Ay40hzVhobpHCIvDGaMnCBE8piGgB9zKGtcleIiUTgToSziFcq6GAY6JThRLhpnKhDNgStO5TEvAfJ9RXQR_QplgIkwFRgzzlugFezbinOnlA96wn58__Th8be6-f7k9fLxrvNSqNK3tNLdkhVJ6tEhcOiX1iHvpXKXCSHLYOaPQaMf3neK2QtuNcjCDJqtu2JtL7jGtvzfKpV9C9jTXG2ndci-0MUJI2ZoqfXuR-rTmnGjsjyksmM694P19F33tor90UcWvH3I3t9DwKP3_fPUPG06IRQ</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Yamada, Yuko</creator><creator>Kinoshita, Hideyuki</creator><creator>Kuwahara, Koichiro</creator><creator>Nakagawa, Yasuaki</creator><creator>Kuwabara, Yoshihiro</creator><creator>Minami, Takeya</creator><creator>Yamada, Chinatsu</creator><creator>Shibata, Junko</creator><creator>Nakao, Kazuhiro</creator><creator>Cho, Kosai</creator><creator>Arai, Yuji</creator><creator>Yasuno, Shinji</creator><creator>Nishikimi, Toshio</creator><creator>Ueshima, Kenji</creator><creator>Kamakura, Shiro</creator><creator>Nishida, Motohiro</creator><creator>Kiyonaka, Shigeki</creator><creator>Mori, Yasuo</creator><creator>Kimura, Takeshi</creator><creator>Kangawa, Kenji</creator><creator>Nakao, Kazuwa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</title><author>Yamada, Yuko ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Nakagawa, Yasuaki ; Kuwabara, Yoshihiro ; Minami, Takeya ; Yamada, Chinatsu ; Shibata, Junko ; Nakao, Kazuhiro ; Cho, Kosai ; Arai, Yuji ; Yasuno, Shinji ; Nishikimi, Toshio ; Ueshima, Kenji ; Kamakura, Shiro ; Nishida, Motohiro ; Kiyonaka, Shigeki ; Mori, Yasuo ; Kimura, Takeshi ; Kangawa, Kenji ; Nakao, Kazuwa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>Arrhythmias, Cardiac - genetics</topic><topic>Arrhythmias, Cardiac - metabolism</topic><topic>Arrhythmias, Cardiac - physiopathology</topic><topic>Arrhythmias, Cardiac - prevention &amp; control</topic><topic>Autonomic Nervous System - drug effects</topic><topic>Autonomic Nervous System - metabolism</topic><topic>Autonomic Nervous System - physiopathology</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Calcium Channels, L-Type - drug effects</topic><topic>Calcium Channels, L-Type - metabolism</topic><topic>Calcium Channels, N-Type - drug effects</topic><topic>Calcium Channels, N-Type - genetics</topic><topic>Calcium Channels, N-Type - metabolism</topic><topic>Cardiomyopathy, Dilated - drug therapy</topic><topic>Cardiomyopathy, Dilated - genetics</topic><topic>Cardiomyopathy, Dilated - metabolism</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Death, Sudden, Cardiac - etiology</topic><topic>Death, Sudden, Cardiac - prevention &amp; control</topic><topic>Dihydropyridines - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Heart - innervation</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - genetics</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - physiopathology</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Nitrendipine - pharmacology</topic><topic>Repressor Proteins - genetics</topic><topic>Repressor Proteins - metabolism</topic><topic>Time Factors</topic><topic>Ventricular Function, Left - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Yuko</creatorcontrib><creatorcontrib>Kinoshita, Hideyuki</creatorcontrib><creatorcontrib>Kuwahara, Koichiro</creatorcontrib><creatorcontrib>Nakagawa, Yasuaki</creatorcontrib><creatorcontrib>Kuwabara, Yoshihiro</creatorcontrib><creatorcontrib>Minami, Takeya</creatorcontrib><creatorcontrib>Yamada, Chinatsu</creatorcontrib><creatorcontrib>Shibata, Junko</creatorcontrib><creatorcontrib>Nakao, Kazuhiro</creatorcontrib><creatorcontrib>Cho, Kosai</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Yasuno, Shinji</creatorcontrib><creatorcontrib>Nishikimi, Toshio</creatorcontrib><creatorcontrib>Ueshima, Kenji</creatorcontrib><creatorcontrib>Kamakura, Shiro</creatorcontrib><creatorcontrib>Nishida, Motohiro</creatorcontrib><creatorcontrib>Kiyonaka, Shigeki</creatorcontrib><creatorcontrib>Mori, Yasuo</creatorcontrib><creatorcontrib>Kimura, Takeshi</creatorcontrib><creatorcontrib>Kangawa, Kenji</creatorcontrib><creatorcontrib>Nakao, Kazuwa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Yuko</au><au>Kinoshita, Hideyuki</au><au>Kuwahara, Koichiro</au><au>Nakagawa, Yasuaki</au><au>Kuwabara, Yoshihiro</au><au>Minami, Takeya</au><au>Yamada, Chinatsu</au><au>Shibata, Junko</au><au>Nakao, Kazuhiro</au><au>Cho, Kosai</au><au>Arai, Yuji</au><au>Yasuno, Shinji</au><au>Nishikimi, Toshio</au><au>Ueshima, Kenji</au><au>Kamakura, Shiro</au><au>Nishida, Motohiro</au><au>Kiyonaka, Shigeki</au><au>Mori, Yasuo</au><au>Kimura, Takeshi</au><au>Kangawa, Kenji</au><au>Nakao, Kazuwa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>104</volume><issue>1</issue><spage>183</spage><epage>193</epage><pages>183-193</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><abstract>Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure. We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice. Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.</abstract><cop>England</cop><pmid>25100767</pmid><doi>10.1093/cvr/cvu185</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-6363
ispartof Cardiovascular research, 2014-10, Vol.104 (1), p.183-193
issn 0008-6363
1755-3245
language eng
recordid cdi_proquest_miscellaneous_1566112286
source Oxford Journals Online
subjects Adrenergic beta-Antagonists - pharmacology
Animals
Anti-Arrhythmia Agents - pharmacology
Arrhythmias, Cardiac - genetics
Arrhythmias, Cardiac - metabolism
Arrhythmias, Cardiac - physiopathology
Arrhythmias, Cardiac - prevention & control
Autonomic Nervous System - drug effects
Autonomic Nervous System - metabolism
Autonomic Nervous System - physiopathology
Calcium Channel Blockers - pharmacology
Calcium Channels, L-Type - drug effects
Calcium Channels, L-Type - metabolism
Calcium Channels, N-Type - drug effects
Calcium Channels, N-Type - genetics
Calcium Channels, N-Type - metabolism
Cardiomyopathy, Dilated - drug therapy
Cardiomyopathy, Dilated - genetics
Cardiomyopathy, Dilated - metabolism
Cardiomyopathy, Dilated - physiopathology
Death, Sudden, Cardiac - etiology
Death, Sudden, Cardiac - prevention & control
Dihydropyridines - pharmacology
Disease Models, Animal
Heart - innervation
Heart Failure - drug therapy
Heart Failure - genetics
Heart Failure - metabolism
Heart Failure - physiopathology
Mice, Knockout
Mice, Transgenic
Nitrendipine - pharmacology
Repressor Proteins - genetics
Repressor Proteins - metabolism
Time Factors
Ventricular Function, Left - drug effects
title Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20N-type%20Ca2+%20channels%20ameliorates%20an%20imbalance%20in%20cardiac%20autonomic%20nerve%20activity%20and%20prevents%20lethal%20arrhythmias%20in%20mice%20with%20heart%20failure&rft.jtitle=Cardiovascular%20research&rft.au=Yamada,%20Yuko&rft.date=2014-10-01&rft.volume=104&rft.issue=1&rft.spage=183&rft.epage=193&rft.pages=183-193&rft.issn=0008-6363&rft.eissn=1755-3245&rft_id=info:doi/10.1093/cvr/cvu185&rft_dat=%3Cproquest_cross%3E1566112286%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1566112286&rft_id=info:pmid/25100767&rfr_iscdi=true